ORG Wealth Partners’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56K Hold
200
﹤0.01% 606
2026
Q1
$3.58K Hold
200
﹤0.01% 568
2025
Q4
$5.4K Hold
200
﹤0.01% 516
2025
Q3
$6.05K Hold
200
﹤0.01% 512
2025
Q2
$5.3K Buy
+200
New +$5.39K ﹤0.01% 547

Other funds holding CAI

ORG Wealth Partners's CAI Position: Q2 2026 in Review

ORG Wealth Partners held its Caris Life Sciences (CAI) position steady in Q2 2026 at 200 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

ORG Wealth Partners first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.05K in Q3 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • ORG Wealth Partners held 200 shares of Caris Life Sciences worth $3.56K as of Q2 2026.
  • ORG Wealth Partners left its Caris Life Sciences share count unchanged in Q2 2026.
  • Caris Life Sciences made up ﹤0.01% of ORG Wealth Partners's portfolio in Q2 2026, its #606 holding.
  • ORG Wealth Partners first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • ORG Wealth Partners's Caris Life Sciences position peaked at $6.05K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.